DorisQuonMD

PubMed

• Artificial Oxygen Carriers Save Lives in Expanded Access Use: Three Cases when Blood Was Not an Option.
  Zhen W Mei, Jay S Raval, Justin Arnall, Sophia H Hwang, Karen Rodberg
  American Journal of Therapeutics. 2025-01-07
• Invasive procedures and surgery following etranacogene dezaparvovec gene therapy in people with hemophilia B.
  Niamh O'Connell, Paul van der Valk, Sandra Le Quellec, Esteban Gomez, Paul E Monahan
  Journal of Thrombosis and Haemostasis. 2025-01-01
• Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
  Andrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V Quon
  Research and Practice in Thrombosis and Haemostasis. 2024-11-01

Journal Articles

• BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A  
  Doris V Quon, Margaret V Ragni, The New England Journal of Medicine
• Development and Reliability of the Joint Tissue Activity and Damage Examination for Quantitation of Structural Abnormalities by Musculoskeletal Ultrasound in Hemophili...  
  Eric Y Chang, Annette von Drygalski, Doris V Quon, Tudor H Hughes, Journal of Ultrasound in Medicine

Abstracts/Posters

• Quantitative Measurements of Hemophilic Joint Tissues By Point-of-Care Musculoskeletal Ultrasound Are Associated with Clinical and Functional Joint Outcome Parameters
  Doris Quon, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019